OAM
Oppenheimer Asset Management Portfolio holdings
AUM
$8.72B
1-Year Return
19.29%
This Quarter Return
-0.56%
1 Year Return
+19.29%
3 Year Return
+71.82%
5 Year Return
+126.54%
10 Year Return
+242.9%
AUM
$8.06B
AUM Growth
-$169M
(-2.1%)
Cap. Flow
+$21.5M
Cap. Flow
% of AUM
0.27%
Top 10 Holdings %
Top 10 Hldgs %
17.56%
Holding
1,218
New
66
Increased
664
Reduced
385
Closed
97
Top Buys
| 1 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
$28.6M |
| 2 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
$21.2M |
| 3 |
Lennar Class A
LEN
|
$20.2M |
| 4 |
FedEx
FDX
|
$15.4M |
| 5 |
Aon
AON
|
$15.2M |
Top Sells
| 1 |
iShares Russell 1000 Value ETF
IWD
|
$44M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$33.4M |
| 3 |
JPMorgan Chase
JPM
|
$31.7M |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$23.2M |
| 5 |
Apple
AAPL
|
$16.1M |
Sector Composition
| 1 | Technology | 19.38% |
| 2 | Financials | 14.72% |
| 3 | Healthcare | 12.31% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Trupanion
TRUP
$1.9B
| $259K | ﹤0.01% |
6,958
-493
| -7% | -$18.4K |
|
1002
Ultragenyx Pharmaceutical
RARE
$3.07B
| $259K | ﹤0.01% |
7,140
+1,173
| +20% | +$42.5K |
|
|
ECG
1003
Everus Construction Group, Inc.
ECG
$3.78B
| $258K | ﹤0.01% |
6,950
+255
| +4% | +$9.46K |
|
1004
Verra Mobility
VRRM
$3.97B
| $258K | ﹤0.01% |
11,451
+2,823
| +33% | +$63.5K |
|
1005
Insight Enterprises
NSIT
$4.02B
| $255K | ﹤0.01% |
+1,703
| New | +$255K |
|
|
LINE
1006
Lineage, Inc. Common Stock
LINE
$9.29B
| $252K | ﹤0.01% |
+4,290
| New | +$252K |
|
1007
Kilroy Realty
KRC
$5.05B
| $251K | ﹤0.01% |
+7,649
| New | +$251K |
|
1008
Albemarle
ALB
$9.6B
| $250K | ﹤0.01% |
3,474
+458
| +15% | +$33K |
|
1009
iShares Expanded Tech-Software Sector ETF
IGV
$9.85B
| $247K | ﹤0.01% |
2,777
-7,164
| -72% | -$638K |
|
1010
First Hawaiian
FHB
$3.21B
| $247K | ﹤0.01% |
10,088
+142
| +1% | +$3.47K |
|
1011
Carter's
CRI
$1.05B
| $244K | ﹤0.01% |
5,969
-1,845
| -24% | -$75.5K |
|
1012
Concentrix
CNXC
$3.39B
| $243K | ﹤0.01% |
+4,366
| New | +$243K |
|
1013
Skyward Specialty Insurance
SKWD
$2.03B
| $241K | ﹤0.01% |
+4,561
| New | +$241K |
|
1014
Federal Agricultural Mortgage
AGM
$2.25B
| $239K | ﹤0.01% |
1,276
+16
| +1% | +$3K |
|
1015
Confluent
CFLT
$6.67B
| $237K | ﹤0.01% |
10,108
-296
| -3% | -$6.94K |
|
1016
SentinelOne
S
$6.25B
| $235K | ﹤0.01% |
12,918
+1,136
| +10% | +$20.7K |
|
1017
Phinia Inc
PHIN
$2.28B
| $233K | ﹤0.01% |
5,498
+560
| +11% | +$23.8K |
|
1018
Hyatt Hotels
H
$13.8B
| $233K | ﹤0.01% |
1,901
-1,118
| -37% | -$137K |
|
1019
Pentair
PNR
$18.1B
| $231K | ﹤0.01% |
+2,645
| New | +$231K |
|
1020
Ameris Bancorp
ABCB
$5.08B
| $230K | ﹤0.01% |
3,996
+116
| +3% | +$6.68K |
|
1021
Krystal Biotech
KRYS
$4.35B
| $229K | ﹤0.01% |
+1,269
| New | +$229K |
|
1022
Restaurant Brands International
QSR
$20.7B
| $227K | ﹤0.01% |
+3,407
| New | +$227K |
|
1023
Knowles
KN
$1.85B
| $226K | ﹤0.01% |
14,881
+4,699
| +46% | +$71.4K |
|
1024
Avidity Biosciences
RNA
$6.48B
| $226K | ﹤0.01% |
+7,657
| New | +$226K |
|
1025
Immunocore
IMCR
$1.87B
| $225K | ﹤0.01% |
+7,574
| New | +$225K |
|